Rabies vaccine study for people with weak immune systems or older age
Part of Immune system & allergy, Infections clinical trials.
This study tests how well a rabies vaccine works and how safe it is for people whose immune systems may be weaker, such as those with certain long-term illnesses, organ transplants, or age 60 and older. It compares them to healthy adults ages 18 to 59.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been exposed to rabies (Category II or III) and need the vaccine after exposure.
- If you are age 18 to 59 and healthy, you can join the control group.
- If you have long-term immune system problems (like certain cancers, autoimmune diseases, or organ transplants), you may join the study group.
- If you have diabetes, chronic hepatitis, liver cirrhosis, kidney disease, or are age 60 or older, you may also join the study group.
- You must agree to follow the study schedule and sign a consent form.
- You cannot have had a rabies vaccine before or have HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new rabies vaccine to see how well it works and if it is safe for people who have not been exposed to rabies. It may be a good option if you want protection before potential exposure.
This trial tests a freeze-dried rabies vaccine to see how safe it is when given on different schedules. It may be an option for people who need protection from rabies.
This trial tests a new lyophilized rabies vaccine to see how well it works and how safe it is. It is for people who have not been vaccinated against rabies recently and have not been bitten or scratched by an animal that broke the skin in the past year.
This trial tests whether different batches of an experimental rabies vaccine work the same way. It is for healthy adults aged 18 to 45 who have not been exposed to rabies or received rabies treatment before.
This trial tests a new freeze-dried rabies vaccine made from human cells. It is for people who may need protection against rabies after a possible exposure, and the study will compare it to standard rabies vaccines.
This trial checks how well a rabies booster shot works in healthy adults who had rabies pre-exposure shots at least 5 years ago. It compares three different booster schedules to see which one best protects against rabies.
Hear when a new Immunocompromised trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.